Filing Details

Accession Number:
0001209191-22-003186
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-13 16:26:46
Reporting Period:
2022-01-11
Accepted Time:
2022-01-13 16:26:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1868734 Cincor Pharma Inc. CINC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1901033 Marc Garidel De C/O Cincor Pharma, Inc
200 Clarendon Street, 6Th Floor
Boston MA 02116
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-11 12,500 $16.00 12,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct